Pancrelipase



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 43.1%
Pancreatic Disorder 23.5%
Pancreatitis 19.6%
Cystic Fibrosis 11.8%
Pancreatitis Chronic 2.0%
Large Intestinal Obstruction 20.0%
Intestinal Ulcer 13.3%
Colitis 6.7%
Death 6.7%
Forced Expiratory Volume Decreased 6.7%
Intestinal Haemorrhage 6.7%
Intestinal Obstruction 6.7%
Large Intestine Polyp 6.7%
Nausea 6.7%
Small Intestinal Stenosis 6.7%
Toxicity To Various Agents 6.7%
Volvulus 6.7%
Secondary
Product Used For Unknown Indication 28.7%
Pancreatic Disorder 17.6%
Cystic Fibrosis 14.7%
Pancreatitis 14.7%
Completed Suicide 4.4%
Pain 3.7%
Mental Disorder 2.9%
Adenocarcinoma Pancreas 1.5%
Back Pain 1.5%
Drug Use For Unknown Indication 1.5%
Hypertension 1.5%
Intervertebral Disc Degeneration 1.5%
Pancreatic Insufficiency 1.5%
Anxiety 0.7%
Blood Cholesterol Increased 0.7%
Breakthrough Pain 0.7%
Convulsion 0.7%
Impaired Gastric Emptying 0.7%
Thyroid Disorder 0.7%
Respiratory Arrest 18.2%
Large Intestine Polyp 15.2%
Intestinal Obstruction 9.1%
Large Intestinal Obstruction 9.1%
Completed Suicide 6.1%
Intestinal Ulcer 6.1%
Toxicity To Various Agents 6.1%
Colitis 3.0%
Dizziness 3.0%
Intestinal Haemorrhage 3.0%
Neutrophil Count Decreased 3.0%
Oesophageal Ulcer 3.0%
Poisoning 3.0%
Product Quality Issue 3.0%
Small Intestinal Stenosis 3.0%
Therapeutic Agent Toxicity 3.0%
Volvulus 3.0%
Concomitant
Product Used For Unknown Indication 34.1%
Pain 8.4%
Drug Use For Unknown Indication 5.9%
Cystic Fibrosis 5.3%
Pancreatic Carcinoma 5.2%
Hypertension 4.9%
Diabetes Mellitus 4.6%
Diarrhoea 4.1%
Prophylaxis 3.3%
Hiv Infection 3.0%
Nausea 3.0%
Pancreatic Insufficiency 2.7%
Nuclear Magnetic Resonance Imaging 2.5%
Depression 2.3%
Gastrooesophageal Reflux Disease 2.2%
Adenocarcinoma Pancreas 1.9%
Abdominal Pain 1.8%
Anaemia 1.7%
Rash 1.5%
Anxiety 1.4%
Vomiting 10.4%
Weight Decreased 9.4%
Hypophosphataemia 7.3%
Thrombocytopenia 7.3%
Cystic Fibrosis 5.2%
Pulmonary Embolism 5.2%
Respiratory Failure 5.2%
Small Intestinal Obstruction 5.2%
Death 4.2%
Eye Disorder 4.2%
Pain 4.2%
Pneumothorax 4.2%
Sepsis 4.2%
Vision Blurred 4.2%
White Blood Cell Count Decreased 4.2%
Bacterial Sepsis 3.1%
Dehydration 3.1%
Depression 3.1%
Mucosal Inflammation 3.1%
Nausea 3.1%